Mar 2, 2026 04:05PM
Feb 24, 2026 08:05AM
Feb 19, 2026 09:40PM
Feb 19, 2026 09:40PM
Feb 19, 2026 04:05PM
Feb 19, 2026 04:05PM
Feb 19, 2026 04:02PM Candel Therapeutics secures $100M royalty funding deal with RTW
Feb 19, 2026 04:01PM
Feb 11, 2026 08:05AM
Feb 2, 2026 04:05PM
Nov 17, 2025 04:05PM
Nov 17, 2025 04:05PM
Nov 13, 2025 08:25AM
Nov 4, 2025 09:00AM Candel Therapeutics to present phase 3 prostate cancer trial results at SITC
Nov 4, 2025 09:00AM
Nov 3, 2025 08:05AM
Oct 16, 2025 08:05AM
Oct 16, 2025 08:05AM
Oct 14, 2025 08:12AM
Oct 14, 2025 08:10AM
Oct 14, 2025 08:10AM Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
Oct 14, 2025 08:07AM
Oct 14, 2025 08:05AM
Oct 7, 2025 06:47AM
Oct 3, 2025 09:05AM
Sep 29, 2025 08:05AM
Sep 29, 2025 08:05AM
Sep 17, 2025 08:05AM Candel Therapeutics to present phase 3 prostate cancer data at ASTRO
Sep 17, 2025 08:05AM
Sep 2, 2025 08:05AM
Sep 2, 2025 08:05AM
Aug 28, 2025 08:05AM
Aug 14, 2025 08:05AM
Jul 30, 2025 08:05AM
Jul 24, 2025 08:06AM Candel receives EMA orphan designation for pancreatic cancer drug
Jul 24, 2025 08:05AM
Jul 14, 2025 06:16AM
Jul 9, 2025 04:46PM
Jul 9, 2025 08:08AM
Jul 9, 2025 08:05AM
Jun 30, 2025 06:41AM
Jun 24, 2025 09:06AM Candel Therapeutics (CADL) Announces $15 million Registered Direct Offering of Common Stock
Jun 24, 2025 09:05AM
Jun 23, 2025 08:05AM
Jun 23, 2025 08:05AM
Jun 6, 2025 08:07AM
Jun 6, 2025 08:05AM
May 28, 2025 08:05AM
May 28, 2025 08:05AM Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
May 27, 2025 08:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All